论文部分内容阅读
在慢性布病的发病机制中,包括有免疫反应系统——细胞免疫的机能障碍。因此,使用免疫强化制剂来促进细胞免疫的恢复,将有助于谩性布病的无反应性患者。在先前的工作中,我们曾单用左旋咪唑,疗程6个月,治疗了10例慢性布病患者。在头2个月症状变化如下,3例恶化,3例改善,3例无变化,仅1例患者症状消失。疗程结束
In the pathogenesis of chronic brucellosis, including the immune response system - the cellular immune dysfunction. Therefore, the use of immunopotentiating agents to promote the recovery of cellular immunity will help atrophy patients with non-responsive brucellosis. In previous work, we had levamisole alone for 6 months and treated 10 patients with chronic brucellosis. In the first two months, the symptoms were as follows: 3 cases deteriorated, 3 improved, 3 unchanged, and only 1 patient disappeared. End of treatment